Cohort 12 RAM Scholars (2023-25)
Abdul Alim, MD
Addiction Medicine
Boston Medical Center
Dr. Alim is an Addiction Medicine Fellow at Boston Medical Center. His RAMS research project focuses on overdose prevention education, Naloxone distribution, and SUD treatment among youth. It is qualitative research studying beliefs and attitudes of Massachusetts school-based health centers health care providers towards substance use disorders among youth as well as feasibility, facilitators and barriers of SUD treatment, overdose prevention and Naloxone distribution to youth in school-based health centers.
Eno Eyo, MD
Addiction Medicine
Vanderbilt University
Dr. Eyo is an Addiction Medicine Fellow at Vanderbilt University. He completed Family Medicine Residency training at Meharry Medical College. He has endearing interest in improving healthcare delivery, bridging gaps in care among underserved population and integrating Addiction medicine / SUD treatments into primary care with goal of providing holistic care with patient centered model. His RAMS project will seek to understand infectious disease Hep C infection among person who injects drugs (PWID) utilizing Syringe Service Program (SSP), the barriers to testing, barriers to treatment, and investigate channels to connect PWID with treatment options to alleviate burden of disease.
Gordon Hill, MD, MS
Addiction Medicine
Yale School of Medicine
Dr. Hill is an Addiction Medicine Fellow at Yale University who is studying the long-term effects of opioids on the immune system. His project seeks to use a subset of patients from the Veterans Aging Cohort Study to describe the role that prescribed opioids have on markers of inflammation in patients with and without HIV. Ultimately this work will improve our ability to care for an aging HIV+ population and potentially lead to novel markers of OUD and opioid tolerance.
Daniel Liauw, MD
Addiction Medicine
Massachusetts General Hospital
Dr. Liauw is an Addiction Medicine Fellow at Massachusetts General Hospital. He completed internal medicine primary care residency at Brigham & Women’s Hospital and earned his AAHIVM certification through street outreach and HIV primary care experiences at Boston Healthcare for the Homeless. His RAMS research project aims to understand racial and ethnic disparities in inpatient naltrexone (oral and injectable) prescribing as well as determine the relationship between naltrexone prescription and alcohol liver disease progression.
Scott Matthews, MD
Addiction Medicine
Yale School of Medicine
Dr. Matthews is the Interprofessional Advanced Fellow in Addiction Treatment at the West Haven VA / Yale School of Medicine site. He is interested in developing novel approaches to treating substance use disorders. His RAMS project will use virtual reality to investigate the role of subjective experience in psychedelic-assisted therapy for alcohol use disorder.
Asha Neptune, MD, MA, MPH
Addiction Medicine
Howard University
Dr. Neptune is an Addiction Medicine Fellow at Howard University Hospital. Through her work as a Pediatric Hospitalist prior to fellowship Dr. Neptune developed a strong interest in adolescent SUD and public health approaches to addressing unhealthy substance use, including prevention and harm reduction strategies. For her RAMS research project, Dr. Neptune will complete a case series detailing several adolescent patients undergoing off-label use of monthly extended-release buprenorphine (Sublocade) injections for the treatment of OUD. Currently, Sublocade is only FDA approved for adults. As part of her research, Dr. Neptune will also assess the willingness of adolescents to receive Sublocade for the treatment of OUD if offered.